Thats why many obesity specialists view these drugs as short-term tools , not permanent solutions
Thats ending
In Phase 2 trials, retatrutide, a GIP/GLP-1/glucagon based triple agonist, achieved a mean bodyweight reduction of up to 24.2% over 48 weeks
Tips for Getting the Best Results To maximize your results, consider focusing on: Eating adequate protein Staying hydrated Strength training regularly Prioritizing sleep Managing stress Staying physically active Following your providers recommendations Combining healthy habits with treatment may help improve long-term success
That recognition is richly deserved, since it is unclear if the GLP-1 drug path to obesity treatment, and all of the associated benefits, would have been seen at this time without her influence
Por otro lado, el GIP ha demostrado ayudar a regular la grasa corporal